PGEN beat EPS expectations by 30.68%
Mar 25, 2025, 10:33 AM
-5.56%
What does PGEN do
Precigen, a biotechnology company headquartered in Germantown, Maryland, focuses on synthetic biology technologies and develops therapies for urgent diseases. Founded in 2013, it operates through Biopharmaceuticals and Exemplar segments.
Precigen (PGEN) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Precigen's actual EPS was -$0.04, beating the estimate of -$0.06 per share, resulting in a 30.68% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.